Issued Patents All Time
Showing 25 most recent of 122 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12064437 | Methods for treating systemic lupus erythematosus and the use of biomarkers as a predictor of clinical sensitivity to therapies | Shaojun Tang | 2024-08-20 |
| 11660302 | 3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus | Lei Wu, Ying Ye | 2023-05-30 |
| 11524950 | Treatment of immune-related and inflammatory diseases | Ying Ye, Donna J. Sutherland, Rajesh Chopra, Anita Gandhi | 2022-12-13 |
| 11357775 | Combination therapies comprising apremilast and Tyk2 inhibitors | Robert Plenge, Mary Adams, Lisa Beebe, Gilles Buchwalter, Tiffany Carr +1 more | 2022-06-14 |
| 11260046 | (+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof | George W. Muller, Hon-Wah Man, Chuansheng Ge | 2022-03-01 |
| 11040024 | Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | George W. Muller, Hon-Wah Man, Chuansheng Ge | 2021-06-22 |
| 10980812 | 3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus | Lei Wu, Ying Ye | 2021-04-20 |
| 10919883 | Treatment of immune-related and inflammatory diseases | Rajesh Chopra, Anita Gandhi | 2021-02-16 |
| 10751414 | Methods of treating psoriasis using PD-1 binding antibodies | Henry Hin Lee Chan, Eun Mi Hur, Roli Khattri, Monica Wai Ling Leung, Garth E. Ringheim | 2020-08-25 |
| 10610516 | Methods of using (+)- 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione | George W. Muller, Hon-Wah Man, Chuansheng Ge | 2020-04-07 |
| 10596179 | 3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus | Lei Wu, Ying Ye | 2020-03-24 |
| 10245266 | 3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus | Lei Wu, Ying Ye | 2019-04-02 |
| 10092542 | Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | George W. Muller, Hon-Wah Man, Chuansheng Ge | 2018-10-09 |
| 10047151 | Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor | Antonia Lopez-Girona, Anita Gandhi, Derek Mendy, Thomas O. Daniel | 2018-08-14 |
| 10018637 | Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast | Matthew William Burnell Trotter | 2018-07-10 |
| 9857359 | Methods for determining drug efficacy using cereblon-associated proteins | Rajesh Chopra, Antonia Lopez-Girona, Laura Corral, Maria Yinglin Wang, Pilgrim Jackson | 2018-01-02 |
| 9724330 | Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | George W. Muller, Hon-Wah Man, Chuansheng Ge | 2017-08-08 |
| 9487519 | 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | Jordi Blasco, Carsten Blettner, Bernd Muller, Markus Gewehr, Wassilios Grammenos +10 more | 2016-11-08 |
| 9480676 | Use of PDE4 inhibitors and combinations thereof for the treatment of cystic fibrosis | Shimon Korish | 2016-11-01 |
| 9433606 | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof | George W. Muller, Hon-Wah Man, Chuansheng Ge, Jean Xu | 2016-09-06 |
| 9387195 | Methods for treating diseases using isoindoline compounds | Sai Shankar | 2016-07-12 |
| 9365640 | Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor | Antonia Lopez-Girona, Anita Gandhi, Derek Mendy, Thomas O. Daniel | 2016-06-14 |
| 9283207 | Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | George W. Muller, Hon-Wah Man, Chuansheng Ge | 2016-03-15 |
| 9272035 | Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases | Anita Gandhi, Lori Capone | 2016-03-01 |
| 9018243 | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof | George W. Muller, Hon-Wah Man, Chuansheng Ge, Jean Xu | 2015-04-28 |